Atossa Therapeutics Inc. (ATOS)

NASDAQ: ATOS · Real-Time Price · USD

0.85

-0.05 (-5.33%)

At close: May 01, 2025, 3:59 PM

0.85

0.27%

Pre-market: May 02, 2025, 06:07 AM EDT

Atossa Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	71.08M	88.46M	110.89M	136.38M	39.55M	12.58M	10.38M	7.22M	3.03M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	1.71M	4.7M	n/a	-3.79K	-10.78K	n/a	n/a	n/a
Other Long-Term Assets	1.99M	2.32M	634K	1K	17.22K	17.22K	17.22K	178.91K	194.25K
Receivables	n/a	-1.43M	743K	1.07M	634.94K	739.66K	n/a	358.28K	n/a
Inventory	n/a	1.49M	4.14M	2.6M	1.92M	972.34K	619.83K	305.94K	n/a
Other Current Assets	229K	110K	1.32M	1.3M	671.88K	136.13K	659.04K	71.34K	55K
Total Current Assets	74.46M	92.22M	118.2M	141.24M	42.77M	14.32M	11.55M	7.9M	3.25M
Property-Plant & Equipment	n/a	n/a	n/a	20K	38.69K	84.48K	54.49K	11.47K	55.12K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	13.38K	68.54K	99.38K	75.69K	640.44K
Total Long-Term Assets	1.99M	4.03M	5.33M	22K	69.28K	170.24K	171.08K	266.06K	889.81K
Total Assets	76.44M	96.25M	123.53M	141.26M	42.84M	14.49M	11.72M	8.16M	4.14M
Account Payables	679K	806K	2.96M	1.72M	1.59M	293.17K	353.33K	334.9K	254.32K
Deferred Revenue	n/a	n/a	n/a	n/a	1.06M	977.31K	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	18.05K	39.37K	n/a	n/a	n/a
Other Current Liabilities	3.04M	1.8M	1.08M	225K	13.08M	51.41K	217.01K	105.64K	89.09K
Total Current Liabilities	4.97M	5.24M	5.57M	3.13M	15.67M	1.32M	2.92M	1.23M	1.05M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-1K	-1K	-3.79K	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	2.96M	1K	3.79K	11.11K	353.33K	334.9K	254.32K
Total Liabilities	4.97M	5.24M	5.57M	3.13M	15.67M	1.33M	2.92M	1.23M	1.05M
Total Debt	n/a	n/a	n/a	n/a	18.05K	50.48K	n/a	n/a	n/a
Common Stock	23.49M	22.79M	22.79M	22.79M	8.56M	1.64M	1.05M	477.34K	56.8K
Retained Earnings	-211.79M	-186.29M	-156.19M	-129.23M	-111.9M	-94.07M	-76.83M	-65.43M	-57.3M
Comprehensive Income	n/a	0.00	-0.00	-582K	n/a	-0.00	n/a	-159.45K	-155.41K
Shareholders Equity	71.48M	91.02M	117.96M	138.14M	27.17M	13.16M	8.81M	6.94M	3.1M
Total Investments	n/a	1.71M	4.7M	n/a	-3.79K	-10.78K	n/a	n/a	n/a